Teladoc (TDOC) closed unchanged, underperforming, with predicted declines in EPS and revenue

From Nasdaq: 2025-01-03 18:15:20

Teladoc (TDOC) closed at $9.52, unchanged from the previous day, underperforming the S&P 500 and Nasdaq. Shares dropped 11.77% in the past month. Earnings estimates predict a 17.65% decline in EPS and a 3.36% decrease in revenue. Teladoc is currently a Zacks Rank #3 (Hold) in the Medical Services industry.

Zacks Research Chief identifies a top stock poised to double in value, targeting millennial and Gen Z markets with nearly $1 billion in revenue last quarter. This stock has potential for explosive growth, even surpassing previous Zacks’ picks like Nano-X Imaging, which rose +129.6% in 9 months.

Zacks Industry Rank indicates the Medical Services industry is in the top 35%. Research shows top-ranked industries outperform lower-ranked ones 2 to 1. For more information on this and other metrics, visit Zacks.com.



Read more at Nasdaq: Teladoc (TDOC) Flat As Market Gains: What You Should Know